InsiderClue
← All stocks

Apimeds Pharmaceuticals US, Inc.

APUS Net buying
CIK 0001894525 #5370 in the set updated 21 Sep 2026
Bought (120 mo)
$2.11M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$2.11M
+$2.11M against sales at will

By person

4 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Inscobee Inc. entity
10% owner
$2.00M (1)
—
+$2.00M
6,416,365
42.52%
$11.93M
+14.2%
Koo Jakap
Director
$56.72K (1)
—
+$56.72K
643,885
4.27%
$1.20M
+4.6%
Kim Christopher
Chairman and CMO
$50.36K (2)
—
+$50.36K
277,500
1.84%
$516.15K
—
Emerson Erik C.
Chief Executive Officer
—
—
—
750,000
4.97%
$1.40M
—

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
Kim Christopher
14 May 2025
Chairman and CMO
Buy
7,730
$1.86
$14.38K
Kim Christopher
13 May 2025
Chairman and CMO
Buy
19,770
$1.82
$35.98K
Inscobee Inc.
12 May 2025
10% owner
Buy
500,000
$4.00
$2.00M
Koo Jakap
12 May 2025
Director
Buy
28,500
$1.99
$56.72K
Show all 7 transactions →

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,297,133
History held since 14 May 2025